Several investors exited the SoftBank and Mahindra-backed, infant-focused e-commerce platform in a primary and secondary round valuing it at $2bn.

The Amazon and CAA-backed home fitness technology provider was valued at $1.6bn in a series E round that took its total funding to $450m.

CapitalG has reinvested in the online insurance provider in a round valuing it at $4bn and pushing its total funding past the $880m mark.

Pfizer Ventures joined existing investors Ipsen and Leaps by Bayer and Pfizer Ventures in a round taking the oncology drug developer's overall funding to $174m.

The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.

The developer of epigenetic medicine, based on Whitehead Institute research, pulled in funding through a round led by founding investor Flagship Pioneering.

Lilly Asia Ventures participated in a series A-plus-plus round pushing the genome editing technology developer's total funding past $100m.

The grocery e-commerce marketplace’s latest round was co-led by Alibaba, and the proceeds will be used to boost its supply chain capabilities and product range.

Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.

Susquehanna Growth Equity has returned to back the Citi and PNG-backed accounting software provider’s latest round, which was raised at a $3.1bn valuation.